相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
Celia J. A. Morgan et al.
ADDICTION (2009)
Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - A systematic review
Carsten Hjorthoj et al.
ADDICTIVE BEHAVIORS (2009)
Catechol-O-Methyltransferase Valine158Methionine Polymorphism Modulates Brain Networks Underlying Working Memory Across Adulthood
Fabio Sambataro et al.
BIOLOGICAL PSYCHIATRY (2009)
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment
Nico Wegener et al.
BRAIN RESEARCH (2009)
A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia
I. Henseler et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory
Nikolaos Pitsikas et al.
NEUROPHARMACOLOGY (2009)
Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure
Takeshi Enomoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Working memory and long-term memory deficits in schizophrenia: Is there a common substrate?
Jared Xavier Van Snellenberg
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Specific cognitive deficits in a group at genetic high risk of schizophrenia
M. O'Connor et al.
PSYCHOLOGICAL MEDICINE (2009)
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
P. D. Morrison et al.
PSYCHOLOGICAL MEDICINE (2009)
Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study)
Immaculada Baeza et al.
SCHIZOPHRENIA RESEARCH (2009)
Glutamate and the neural basis of the subjective effects of ketamine
J. F. William Deakin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Prediction of psychosis in youth at high clinical risk
Tyrone D. Cannon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Impairment of Working Memory Maintenance and Response in Schizophrenia: Functional Magnetic Resonance Imaging Evidence
Naomi R. Driesen et al.
BIOLOGICAL PSYCHIATRY (2008)
Genetic variation in catechol-O-methyltransferase: Effects on working memory in schizophrenic patients, their siblings, and healthy controls
Catherine M. Diaz-Asper et al.
BIOLOGICAL PSYCHIATRY (2008)
Journey through the K-hole: Phenomenological aspects of ketamine use
L. Muetzelfeldt et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Adolescent cocaine residually impairs working memory and enhances fear memory in rats
Anthony C. Santucci
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2008)
Ecstasy-related deficits in the updating component of executive processes
Catharine Montgomery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Substance-induced psychosis: A diagnostic conundrum
Steve Mathias et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A study investigating the acute dose - response effects of 13 mg and 17 mg Delta 9-tetrahydrocannabinol on cognitive - motor skills, subjective and autonomic measures in regular users of marijuana
A. Weinstein et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory
N. Pitsikas et al.
NEUROSCIENCE (2008)
Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
Francisco J. Alvarez et al.
PEDIATRIC RESEARCH (2008)
A review of the neuropharmacological properties of khat
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Affect processing and positive syndrome schizotypy in cannabis users
Patrick D. Skosnik et al.
PSYCHIATRY RESEARCH (2008)
Abstinent adolescent marijuana users show altered fMRI response during spatial working memory
Alecia D. Schweinsburg et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample
E. Barkus et al.
PSYCHOLOGICAL MEDICINE (2008)
Cannabis-Induced Psychotic-Like Experiences Are Predicted by High Schizotypy
J. Stirling et al.
PSYCHOPATHOLOGY (2008)
MDMA modifies active avoidance learning and recall in mice
Jose Manuel Trigo et al.
PSYCHOPHARMACOLOGY (2008)
Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers
G. J. H. Dumont et al.
PSYCHOPHARMACOLOGY (2008)
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy -: a [123I]CNS-1261 SPET study
James M. Stone et al.
PSYCHOPHARMACOLOGY (2008)
Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice
Ming-Huan Chan et al.
PSYCHOPHARMACOLOGY (2008)
Gene-Environment Interplay Between Cannabis and Psychosis
Cecile Henquet et al.
SCHIZOPHRENIA BULLETIN (2008)
Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia
Matthew J. Smith et al.
SCHIZOPHRENIA RESEARCH (2008)
Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants
James J. Mahoney et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study
P. A. Ringen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice
James M. Doherty et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments
Olivier George et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Spatial working memory performance and fMRI activation interactions in abstinent adolescent marijuana users
Claudia B. Padula et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2007)
Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls
Michelle L. Esterberg et al.
SCHIZOPHRENIA RESEARCH (2007)
The amphetamine-induced sensitized state as a model of schizophrenia
R. E. Featherstone et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Cocaine self-administration improves performance in a highly demanding water maze task
N. Del Olmo et al.
PSYCHOPHARMACOLOGY (2007)
Verbal memory performance improved via an acute administration of D-amphetamine
Inge Zeeuws et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2007)
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats
L. Robinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa H. M. Moore et al.
LANCET (2007)
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment
Akihiro Mouri et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls
Maria C. Jockers-Scheruebl et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Substance use in a population-based clinic sample of people with first-episode psychosis
Jennifer H. Barnett et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Cannabis abuse and risk for psychosis in a prodromal sample
Karin Kristensen et al.
PSYCHIATRY RESEARCH (2007)
Iowa Gambling Task in schizophrenia: A review and new data in patients with schizophrenia and co-occurring cannabis use disorders
Serge Sevy et al.
SCHIZOPHRENIA RESEARCH (2007)
Concurrent alcohol and tobacco use during early adolescence characterizes a group at risk
Brigitte Schmid et al.
ALCOHOL AND ALCOHOLISM (2007)
Patterns, predictors and impact of substance use in early psychosis: a longitudinal study
J. Addington et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis
Victoria Manning et al.
SCHIZOPHRENIA RESEARCH (2007)
Cannabis and psychosis: an update on course and biological plausible mechanisms
Don Linszen et al.
CURRENT OPINION IN PSYCHIATRY (2007)
Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) users
Gary Groth-Marnat et al.
PERCEPTUAL AND MOTOR SKILLS (2007)
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis
Carol L. M. Caton et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
Michael H. Baumann et al.
PSYCHOPHARMACOLOGY (2007)
Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatil information unaffected
Kim P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2007)
The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues
Carissa M. Coulston et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2007)
The relationship between non-acute adolescent cannabis use and cognition
Megan A. Harvey et al.
DRUG AND ALCOHOL REVIEW (2007)
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research
Kelly J. Clemens et al.
DRUG AND ALCOHOL REVIEW (2007)
A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)
Brian J. Piper
NEUROTOXICOLOGY AND TERATOLOGY (2007)
Health habits of patients with schizophrenia
Christiane Roick et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2007)
An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Cecile Henquet et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults
Michelle R. Lofwall et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2006)
Stimulants: Therapeutic actions in ADHD
Amy F. T. Arnsten
NEUROPSYCHOPHARMACOLOGY (2006)
Psychophysiological evidence of altered neural synchronization in cannabis use: Relationship to schizotypy
Patrick D. Skosnik et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
The prevalence of psychotic symptoms among methamphetamine users
Rebecca McKetin et al.
ADDICTION (2006)
Schizotypy, marijuana, and differential item functioning
Mitch Earleywine
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2006)
An evaluation of phencyclidine (PCP) psychosis: A retrospective analysis at a state facility
Katie A. Carls et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2006)
Psychological effects of ketamine in healthy volunteers - Phenomenological study
E. Pomarol-Clotet et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia
S. Mohamed et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Spatial working memory as a cognitive endophenotype of schizophrenia: Assessing risk for pathophysiological dysfunction
Alice M. Saperstein et al.
SCHIZOPHRENIA BULLETIN (2006)
Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans
Karina K. Kedzior et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory
Jessica A. Able et al.
BIOLOGICAL PSYCHIATRY (2006)
Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice
Hiroshi Nagai et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Comorbid substance use and age at onset of schizophrenia
TRE Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Psychiatric endophenotypes and the development of valid animal models
TD Gould et al.
GENES BRAIN AND BEHAVIOR (2006)
Genetically predisposed offspring with schizotypal features: An ultra high-risk group for schizophrenia?
VA Diwadkar et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization
ED Levin et al.
PSYCHOPHARMACOLOGY (2006)
Spatial working memory deficits in adolescents at clinical high risk for schizophrenia
CW Smith et al.
SCHIZOPHRENIA RESEARCH (2006)
Course of substance misuse and daily tobacco use in first-episode psychosis
D Wade et al.
SCHIZOPHRENIA RESEARCH (2006)
The effect of Δ9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats
DT Malone et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Cannabis-induced psychosis-like experiences are associated with high schizotypy
E. J. Barkus et al.
PSYCHOPATHOLOGY (2006)
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
M Arendt et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Transient memory impairment after acute dose of 75 mg 3.4-methytenedioxymethamphetamine
KPC Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers
DM Barch et al.
SCHIZOPHRENIA RESEARCH (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation
CM Tipper et al.
PSYCHOPHARMACOLOGY (2005)
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis
M Lambert et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis
CK Chen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
The environment and schizophrenia: The role of cannabis use
C Henquet et al.
SCHIZOPHRENIA BULLETIN (2005)
Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up
J Stirling et al.
SCHIZOPHRENIA RESEARCH (2005)
Cannabis use and outcome of recent onset psychosis
A Grech et al.
EUROPEAN PSYCHIATRY (2005)
Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex
SA Castner et al.
BIOLOGICAL PSYCHIATRY (2005)
Symptoms of schizotypy precede cannabis use
J Schiffman et al.
PSYCHIATRY RESEARCH (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
△9-THC-induced cognitive deficits in mice are reversed by the GABAA antagonist bicuculline
SA Varvel et al.
PSYCHOPHARMACOLOGY (2005)
Cannabis as a risk factor for psychosis: systematic review
DM Semple et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Selective cognitive impairments associated with NMDA receptor blockade in humans
LM Rowland et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder
S Kumra et al.
SCHIZOPHRENIA RESEARCH (2005)
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats
M Bortolato et al.
PSYCHOPHARMACOLOGY (2005)
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods
MP Viveros et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users
K Heekeren et al.
PSYCHOPHARMACOLOGY (2004)
Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse
T Moller et al.
NORDIC JOURNAL OF PSYCHIATRY (2004)
The relationship between cannabis use and schizotypal symptoms
EL Bailey et al.
EUROPEAN PSYCHIATRY (2004)
Causal association between cannabis and psychosis: examination of the evidence
L Arseneault et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample
DJ Kavanagh et al.
SCHIZOPHRENIA RESEARCH (2004)
Prevalence and correlates of self-reported psychotic symptoms in the British population
LC Johns et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Cocaine in adolescent rats produces residual memory impairments that are reversible with time
AC Santucci et al.
NEUROTOXICOLOGY AND TERATOLOGY (2004)
Stimulant psychosis: systematic review
C Curran et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
W Adriani et al.
BEHAVIOURAL PHARMACOLOGY (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Functional MRI study of working memory in MDMA users
FG Moeller et al.
PSYCHOPHARMACOLOGY (2004)
Nicotinic receptors and schizophrenia
N Ripoll et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Differential effects of THC or CBD-rich cannabis extracts on working memory in rats
P Fadda et al.
NEUROPHARMACOLOGY (2004)
Early adolescent cannabis exposure and positive and negative dimensions of psychosis
NC Stefanis et al.
ADDICTION (2004)
Substance misuse at presentation to an early psychosis program
S Van Mastrigt et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2004)
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CK Chen et al.
PSYCHOLOGICAL MEDICINE (2003)
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
VS Mattay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects
F Sorbara et al.
EUROPEAN PSYCHIATRY (2003)
Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice
Z Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Low dose ketamine increases prepulse inhibition in healthy men
KM Abel et al.
NEUROPHARMACOLOGY (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits
S Mandillo et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Cannabis use and dimensions of psychosis in a nonclinical population of female subjects
H Verdoux et al.
SCHIZOPHRENIA RESEARCH (2003)
Relationships between personality and preferred substance and motivations for use among adolescent substance abusers
JB Adams et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2003)
Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons
RE Hampson et al.
HIPPOCAMPUS (2003)
Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group
LJ Phillips et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2002)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Modulating sensory gating in healthy volunteers: The effects of ketamine and haloperidol
B Oranje et al.
BIOLOGICAL PSYCHIATRY (2002)
The effects and consequences of selected club drugs
TE Freese et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (ecstasy) polydrug users
HC Fox et al.
PSYCHOPHARMACOLOGY (2002)
Precipitation and determination of the onset and course of schizophrenia by substance abuse -: a retrospective and prospective study of 232 population-based first illness episodes
B Bühler et al.
SCHIZOPHRENIA RESEARCH (2002)
SR 141716A prevents Δ9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice
GE Da Silva et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Cannabis use correlates with schizotypal personality traits in healthy students
P Dumas et al.
PSYCHIATRY RESEARCH (2002)
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (Ecstasy)
KC Morley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Characteristics of learning and memory impairment induced by Δ9-tetrahydrocannabinol in rats
K Mishima et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder
S Sevy et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
The incidence of schizotypy among cannabis and alcohol users
JA Nunn et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2001)
Tactile prepuff inhibition of startle in children with Tourette's syndrome: In search of an fMRI-friendly startle paradigm
NR Swerdlow et al.
BIOLOGICAL PSYCHIATRY (2001)
A neurobiological basis for substance abuse comorbidity in schizophrenia
RA Chambers et al.
BIOLOGICAL PSYCHIATRY (2001)
Effects of drugs of abuse on response accuracy and bias under a delayed matching-to-sample procedure in squirrel monkeys
SP Baron et al.
BEHAVIOURAL PHARMACOLOGY (2001)
Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects
R Mass et al.
PSYCHOPATHOLOGY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
MF Egan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Impact of an early psychosis program on substance use
J Addington et al.
PSYCHIATRIC REHABILITATION JOURNAL (2001)
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
S Bhattachary et al.
PSYCHOLOGICAL MEDICINE (2001)
The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being
L Degenhardt et al.
PSYCHOLOGICAL MEDICINE (2001)
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia
DL Braff et al.
SCHIZOPHRENIA RESEARCH (2001)
Implementing dual diagnosis services for clients with severe mental illness
RE Drake et al.
PSYCHIATRIC SERVICES (2001)
Cannabis use is associated with schizotypy and attentional disinhibition
PD Skosnik et al.
SCHIZOPHRENIA RESEARCH (2001)
Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia
MP Salyers et al.
SCHIZOPHRENIA RESEARCH (2001)
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
A Dervaux et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Substance abuse in schizophrenia:: a review of the literature and a study of correlates in Sweden
E Cantor-Graae et al.
SCHIZOPHRENIA RESEARCH (2001)
Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task
JM Aultman et al.
PSYCHOPHARMACOLOGY (2001)
Personality profile and neuropsychological test performance in chronic cocaine-abusers
M Rosselli et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2001)
Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits
KS Cadenhead et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
TJ Ornstein et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Marijuana and medicine: Assessing the science base - A summary of the 1999 institute of medicine report
SJ Watson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Prepulse inhibition of the startle response in men with schizophrenia -: Effects of age of onset of illness, symptoms, and medication
V Kumari et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
The disruptive effect of cocaine on prepulse inhibition is prevented by repeated administration in rats
JJ Byrnes et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients
MR Serper et al.
PSYCHIATRY RESEARCH (2000)
Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later
HV Curran et al.
ADDICTION (2000)
Verbal working memory impairment in schizophrenia patients and their first-degree relatives: Evidence from the digit span task
HM Conklin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder
RM Kirrane et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Effects of dextroamphetamine on cognitive performance and cortical activation
VS Mattay et al.
NEUROIMAGE (2000)
Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients
AI Weike et al.
BIOLOGICAL PSYCHIATRY (2000)
Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups
KT Mueser et al.
SCHIZOPHRENIA BULLETIN (2000)
Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: Evidence for cognitive impulsivity
JD Jentsch et al.
BIOLOGICAL PSYCHIATRY (2000)
Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice
SC Dulawa et al.
NEUROPHARMACOLOGY (2000)
分享论文
